Healthstream (HSTM) FY2018 results: revenue $232 million, up 7.8% on the year
Healthstream Inc. (HSTM) reported revenue of $232 million for fiscal 2018, the year ended 31 December 2018, up 7.8% on the year before. Net income was $32 million, up 222.0%, and diluted earnings per share $1.00. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2019.
Revenue
$232 million
+7.8% on the year
FY2011FY2018
Operating margin
6.7%
4.4% a year earlier
FY2011FY2018
Net income
$32 million
+222.0% on the year
FY2011FY2018
Diluted EPS
$1.00
+222.6% on the year
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
232
215
192
+7.8%
Cost of revenue
96.0
87.2
n/a
+10.1%
Gross profit
136
128
n/a
+6.2%
Gross margin
58.5%
59.4%
n/a
Research and development
25.7
24.1
24.2
+6.6%
Operating income
15.5
9.4
7.2
+64.7%
Operating margin
6.7%
4.4%
3.7%
Pre-tax income
16.6
10.1
7.8
+63.5%
Income tax
3.3
1.3
3.0
+155.3%
Effective tax rate
20.1%
12.8%
38.2%
Net income
32.2
10.0
3.8
+222.0%
Net margin
13.9%
4.7%
2.0%
Diluted EPS
$1.00
$0.31
$0.12
+222.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
43.2
46.7
24.2
-7.4%
Capital expenditure
7.2
5.5
4.8
+29.9%
Free cash flow
36.1
41.2
19.4
-12.4%
Free cash flow margin
15.6%
19.2%
10.1%
Cash from investing
36.6
-11.6
-56.7
Cash from financing
-30.3
0.0
0.0
Depreciation and amortisation
24.2
24.0
20.4
+0.8%
Share-based compensation
1.8
1.7
1.9
+2.4%
Dividends paid
32.4
n/a
n/a
Dividend per share
$1.00
n/a
n/a
Diluted shares, weighted
32m
32m
32m
+0.4%
Shares outstanding at period end
32m
32m
32m
+1.3%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
319
300
286
+6.3%
Debt
0.0
0.0
0.0
Other liabilities
123
111
110
+10.9%
Total liabilities and equity
442
411
396
+7.5%
Fixed assets
15.9
8.1
10.2
+96.1%
Goodwill
86.1
86.1
85.6
0.0%
Intangible assets
59.4
68.5
78.4
-13.3%
Investments
34.5
46.4
53.5
-25.6%
Cash and equivalents
134
84.8
49.6
+58.5%
Receivables
38.1
36.7
44.8
+3.9%
Other assets
73.6
80.5
73.8
-8.6%
Total assets
442
411
396
+7.5%
10-K for the year ended 31 December 2018, filed 25 February 2019: the filing.